Domov › Velika depresivna motnja › Florida
Klinične študije za Velika depresivna motnja v Florida
32 študij za Velika depresivna motnja išče udeležence na lokacijah v Florida.
Mesta v Florida
- Orlando19 študij
- Miami18 študij
- Tampa17 študij
- Jacksonville12 študij
- Hollywood8 študij
- Hialeah8 študij
- West Palm Beach7 študij
- Brandon6 študij
- Miami Gardens5 študij
- Naples4 študij
- Cape Coral4 študij
- Palm Bay3 študij
- Deltona3 študij
Uradno besedilo študije (angleško)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- JEM Research Institute, Atlantis
- Bradenton Research Center, Inc., Bradenton
- Key Clinical Research, Bradenton
- in še 6
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- UHC Research, Doral
- Reliable Clinical Research, Hialeah
- Pharmax Research Clinic Inc, Miami
- in še 3
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Clinical Research of Brandon, Brandon
- AGA Clinical Trials, Hialeah
- Reliable Clinical Research, Hialeah
- in še 9
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Neuroscience Solutions Inc. - Jacksonville, Jacksonville
- K2 Medical Research - Maitland, Maitland
- Central Miami Medical Institute Llc., Miami
- in še 3
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Premier Clinical Research Institute, Miami
- Miami Jewish Health System, Miami
- Interventional Psychiatry of Tampa Bay, Tampa
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- CNS Healthcare, Jacksonville
- Accel Research Sites - Maitland, Maitland
- Aqualane Clinical Research, Naples
- in še 1
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Fort Myers
- Vanda Investigational Site, Miami
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bonita Springs
- Neurocrine Clinical Site, Hialeah
- Neurocrine Clinical Site, Miami
- in še 3
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Jacksonville
- Seaport Investigator Site, Lauderhill
- Seaport Investigator Site, Orlando
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- New Access Research and Medical Services, Inc., Fort Myers
- The Medici Medical Research, Hollywood
- Clinical Neuroscience Solutions, Inc., Orlando
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Gulfcoast Clinical Research Center, Fort Myers
- Sarkis Clinical Trials, Gainesville
- Equipath Health and Research Tampa Bay, Llc, Riverview
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Hialeah
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07610473Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
- Florida State University, Tallahassee
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT06132581Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USF Health, Tampa
Vključevanje udeležencev
Starost 22–70 · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Miami
- Draig Clinical Site, New Port Richey
- Draig Clinical Site, Orlando
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Tampa
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Clinical Neuroscience Solutions, LLC (Jacksonville), Jacksonville
- K2 Medical Research (Maitland), Maitland
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- in še 2
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Miami
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Encore Medical Research, Hollywood
- K2 Medical Research - Maitland, Maitland
- Life Medical Research Group Corp, Miami Gardens
- in še 5
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- CNS Clinical Research Group, Coral Springs
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Accel Research Sites Lakeland, Lakeland
- in še 4
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc., Jacksonville
- D&H Pompano Research Center, LLC, Margate
- Premier Clinical Research Institute, Inc., Miami
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc, Jacksonville
- Premier Clinical Research Institute Inc, Miami
- Aqualane Clinical Research, Naples
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Miami Gardens
- Neurocrine Clinical Site, Orlando
- Neurocrine Clinical Site, Palm Bay
- in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Maitland
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Jacksonville
- Clinical Research Site, Miami
- Clinical Research Site, Miami
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- CenExel Hollywood FL /ID# 278200, Hollywood
- Cns Healthcare - Jacksonville /ID# 277658, Jacksonville
- GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
- in še 2
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Hollywood
- Bioresearch Partner, Miami
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #108, Brandon
- Autobahn Site #110, Hialeah
- Autobahn Site #101, Jacksonville
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. okt. 2025 · NCT06786624Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
- AdventHealth Neuroscience Institute, Orlando
Vključevanje udeležencev
Starost 60 in več · Vsi spoli · Posodobljeno 22. okt. 2025 · NCT05877885Study of ALTO-300 in MDD
- Site 159, Clermont
- Site 225, Miami Gardens
- Site 190, Miami Lakes
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 24. jul. 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Brandon
- Clinical Research Site, Doral
- Clinical Research Site, Hialeah
- in še 5
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2025 · NCT06223880Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.